Stock Analiz

Chemed Corp. (CHE) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Chemed’s revenue went from $1.6B in fiscal 2016 to $2.5B in fiscal 2025, growth of about 5.4% a year.

Net income in fiscal 2025 was $265M, a net margin of 10.5%; the best year in this period was 2020 with $319M.

Over the twelve months to September 30, 2026, revenue was $2.7B and net income $282M.

Free cash flow was $325M in fiscal 2025 and positive in 10 of the 10 years shown.

The diluted share count fell 14% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2016: $1.6B162017: $1.7B172018: $1.8B182019: $1.9B192020: $2.1B202021: $2.1B212022: $2.1B222023: $2.3B232024: $2.4B242025: $2.5B25$2.5B
Net income
2016: $109M162017: $98M172018: $206M182019: $220M192020: $319M202021: $269M212022: $250M222023: $273M232024: $302M242025: $265M25$265M
Free cash flow
2016: $96M162017: $98M172018: $234M182019: $248M192020: $430M202021: $250M212022: $253M222023: $273M232024: $368M242025: $325M25$325M
EPS (diluted)
2016: $6.48162017: $5.86172018: $12.23182019: $13.31192020: $19.48202021: $16.85212022: $16.53222023: $17.93232024: $19.89242025: $18.3425$18.34

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$2.7B$2.5B$2.4B$2.3B$2.1B$2.1B$2.1B$1.9B$1.8B$1.7B$1.6B
Gross profit$893M$823M$854M$799M$765M$770M$701M$617M$555M$516M$461M
Operating income$371M$338M$366M$341M$343M$343M$390M$257M$244M$113M$179M
Net income$282M$265M$302M$273M$250M$269M$319M$220M$206M$98M$109M
EPS (diluted)$20.87$18.34$19.89$17.93$16.53$16.85$19.48$13.31$12.23$5.86$6.48
R&D———————————
Revenue growth—+4.1%+7.4%+6.1%−0.2%+2.9%+7.3%+8.8%+7.0%+5.7%+2.2%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$363M$388M$417M$330M$310M$309M$489M$301M$287M$162M$135M
Capital spending-$68M-$63M-$50M-$57M-$57M-$59M-$59M-$53M-$53M-$64M-$40M
Free cash flow$295M$325M$368M$273M$253M$250M$430M$248M$234M$98M$96M
Dividends paid$34M$32M$27M$24M$22M$22M$21M$20M$19M$17M$16M
Buybacks$525M$432M$361M$68M$115M$576M$176M$93M$159M$95M$102M
Stock-based pay—$39M$52M$41M$34M$31M$27M$21M$19M$16M$14M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$75M$178M$264M$74M$33M$163M$6M$5M$11M$15M
Debt—$144M$141M$139M$247M$324M$135M$216M$89M$101M$109M
Equity—$979M$1.1B$1.1B$799M$623M$901M$727M$591M$540M$524M
Total assets—$1.5B$1.7B$1.7B$1.4B$1.3B$1.4B$1.3B$976M$920M$880M
Shares (diluted)13M14M15M15M15M16M16M17M17M17M17M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin33.5%32.5%35.1%35.3%35.8%36.0%33.7%31.9%31.1%31.0%29.3%
Operating margin13.9%13.4%15.1%15.0%16.1%16.0%18.7%13.3%13.7%6.8%11.3%
Net margin10.6%10.5%12.4%12.0%11.7%12.6%15.4%11.3%11.5%5.9%6.9%
FCF margin11.1%12.9%15.1%12.1%11.8%11.7%20.7%12.8%13.1%5.9%6.1%
ROIC—22.4%22.0%21.2%24.9%27.8%30.3%23.0%30.7%14.8%17.3%
ROE—27.1%27.0%24.6%31.2%43.1%35.4%30.3%34.8%18.2%20.8%

Frequently asked questions

What is Chemed’s annual revenue?

$2.5B in fiscal 2025 and $2.7B over the twelve months to September 30, 2026.

How much profit does Chemed make?

Net income was $265M in fiscal 2025 (net margin 10.5%).

Is Chemed’s revenue growing?

Yes: revenue rose 4.1% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.